Dahlgren Claes, Holdfeldt André, Lind Simon, Mårtensson Jonas, Gabl Michael, Björkman Lena, Sundqvist Martina, Forsman Huamei
Department of Rheumatology and Inflammation Research, University of Göteborg, Göteborg 405 30, Sweden.
ACS Pharmacol Transl Sci. 2020 Mar 11;3(2):203-220. doi: 10.1021/acsptsci.0c00004. eCollection 2020 Apr 10.
Activation as well as recruitment of neutrophils, the most abundant leukocyte in human blood, to sites of infection/inflammation largely rely on surface-exposed chemoattractant receptors. These receptors belong to the family of 7-transmembrane domain receptors also known as G protein-coupled receptors (GPCRs) due to the fact that part of the downstream signaling relies on an activation of heterotrimeric G proteins. The neutrophil GPCRs share significant sequence homologies but bind many structurally diverse activating (agonistic) and inhibiting (antagonistic) ligands, ranging from fatty acids to purines, peptides, and lipopeptides. Recent structural and functional studies of neutrophil receptors have generated important information on GPCR biology in general; this knowledge aids in the overall understanding of general pharmacological principles, governing regulation of neutrophil function and inflammatory processes, including novel leukocyte receptor activities related to ligand recognition, biased/functional selective signaling, allosteric modulation, desensitization mechanisms and reactivation, and communication (cross-talk) between GPCRs. This review summarizes the recent discoveries and pharmacological hallmarks with focus on neutrophil GPCRs. In addition, unmet challenges are dealt with, including recognition by the receptors of diverse ligands and how biased signaling mediates different biological effects.
中性粒细胞是人体血液中最丰富的白细胞,其激活以及募集到感染/炎症部位在很大程度上依赖于表面暴露的趋化因子受体。这些受体属于7跨膜结构域受体家族,由于部分下游信号传导依赖于异源三聚体G蛋白的激活,也被称为G蛋白偶联受体(GPCR)。中性粒细胞GPCR具有显著的序列同源性,但能结合许多结构多样的激活(激动剂)和抑制(拮抗剂)配体,从脂肪酸到嘌呤、肽和脂肽。最近对中性粒细胞受体的结构和功能研究总体上产生了关于GPCR生物学的重要信息;这些知识有助于全面理解一般药理学原理,这些原理支配着中性粒细胞功能和炎症过程的调节,包括与配体识别、偏向/功能选择性信号传导、变构调节、脱敏机制和再激活以及GPCR之间的通讯(串扰)相关的新型白细胞受体活性。本综述总结了最近的发现和药理学特征,重点是中性粒细胞GPCR。此外,还讨论了未解决的挑战,包括受体对不同配体的识别以及偏向信号传导如何介导不同的生物学效应。